Trials / Completed
CompletedNCT01982058
Intimacy-Enhancing Couples' Intervention for Localized Prostate Cancer
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 483 (actual)
- Sponsor
- Rutgers, The State University of New Jersey · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
RATIONALE: Participating in a therapy program may enhance communication and intimacy between men with prostate cancer and their partners. PURPOSE: This randomized clinical trial is studying how well therapy enhances communication and intimacy for men with early stage prostate cancer and for their partners.
Detailed description
Aim 1 A. To evaluate the impact of an Intimacy-Enhancing Couples' intervention (IEC) versus a General Health and Wellness Intervention (GHW) and a Usual care control (UC) on patient and partner psychological and relationship outcomes. B. To determine whether relationship length, pre-intervention relationship satisfaction, and men's pre-intervention masculinity moderate the effects of IEC on couples' psychological and relationship outcomes Aim 2 A. To evaluate whether IEC has an effect on couples' communication and intimacy when compared with GHW and UC and to determine whether changes in relationship communication and intimacy mediate changes in couples' psychological and relationship outcomes. Exploratory Aim: A. To evaluate the impact of IEC versus GHW on physical activity and fruit and vegetable intake as well as each partner's support for the other partner's adoption of greater physical activity and more fruit and vegetable intake.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | communication intervention | |
| OTHER | counseling intervention | |
| OTHER | nutrition intervention | |
| OTHER | questionnaire administration |
Timeline
- Start date
- 2011-08-18
- Primary completion
- 2017-08-07
- Completion
- 2017-08-07
- First posted
- 2013-11-13
- Last updated
- 2022-10-19
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01982058. Inclusion in this directory is not an endorsement.